Partager cette page


Sr. Scientist, Antibody Discovery, Société CILOA

CILOA, a Biotech located in south of France, with a disruptive technology in the use of challenging proteins as immunogens is looking for an energetic Research Scientist with strong hands-on experience in immunology, cellular and molecular biology for a permanent position (CDI). Using state-of-the-art technologies, he will isolate antibody cDNA from single B cells. He will create a platform aiming to develop therapeutic antibodies. His success will contribute to our mission in the development of innovative therapeutics targeting so-called “undruggable” proteins involved in several types of pathologies.

Offered:

Opportunities to break new ground trusting you with responsibility early on and allowing you to fulfill your ambitions, and to draw your own career map that is responsive to your aspirations and priorities in life. Bring your imagination and skills to life!

Mission and key responsibilities:

  • Create and lead the platform of antibody generation using single B cell cloning strategy.

  • Design, execute and analyze experimental studies, propose creative solutions to troubleshoot problems, and proactively research new methods to improve processes.

  • Perform molecular and cellular biology experiments, including RT-PCR, PCR, recombinant DNA cloning, plasmid preps, bacterial transformation, mammalian cell culture, mammalian transfection for transient protein expression.

  • Conduct different assays: FACS, ELISA, Western blotting, BLI and SPR based Ab screening.

  • Collaborate and support other team members effectively to enhance productivity of the group and accomplish organizational goals.

  • Assist with process improvements by thinking critically about the design and execution of experiments, including automation, and SOP development.

  • With strong attention to detail, perform excellent record-keeping, time-management and organization to achieve group and company deliverables.

Required experience and skills:

  • Ph.D. in Molecular Biology, Immunology, or Cell Biology, with a minimum of 3+ years required; a post doc in relevant field a plus.

  • Experience in antibody generation strategies is desired; antibody engineering, optimization of effector function, affinity and biophysical properties a plus.

  • Experience with B cell biology with a solid background in mouse and human adaptive immune system, and in B/T cell differentiation.

  • Technical proficiency in molecular biology.

  • Mastery of sterile cell culture is a must.

  • Experience in multi-parameter/multi-color flow cytometry is desired. Knowledge of Flow cytometry based cell sorting is a plus.

  • Hands-on experience in antibody discovery methods, including advanced B-cell cloning is desired; hybridoma techniques, phage, yeast or/and mammalian display and other display technologies a plus.

  • Expertise in therapeutic antibody is desirable but not essential.

  • Familiarity with HTP automated recombinant protein expression is a plus.

  • Demonstrated ability to be proactive, diligent and reliable to meet deadlines. Excellent organization and planning skills.

  • Must be highly collaborative, team-oriented, yet with the ability to work independently.

  • Excellent interpersonal, verbal and written communication skills are required. Attention to detail and analytical.

  • Fluent English both written and verbal; French is a plus.

Applications should include: Send at contact(at)ciloa(dot)fr, a cover letter, CV, statement of research interests, and contact information for potential references.

Actualité

Rendez-vous Healthtech à Nice

Le marché américain : l’eldorado pour les biotech et les medtech ?

 

La CCI Nice Côte d'Azur en partenariat avec MD 101 vous invite au :

1er Rendez-vous healthtech Côte d’Azur

Le marché américain :

l’eldorado pour les biotech et les medtech ?

 

Mardi 27 Juin 2017 - 9h-11h30

Golden Tulip

120 Route des Macarons, Sophia Antipolis

 

Le marché américain, du fait de sa taille, est une cible prioritaire pour le développement des biotech et medtech françaises.

 

Comment aborder ce marché complexe ?

 

Venez rencontrer des experts des questions réglementaires, de marketing, de développement commercial et de gestion des  risques, ainsi que des entreprises qui viendront témoigner pour partager bonnes pratiques, points de vigilance

et retours d'expérience.

 

Programme

 

8h45 : Accueil - Café

9h00 : Introduction : : Le marché biotech / medtech US, chiffres-clés, principaux clusters - Mathieu Cynober, In Extenso Innovation Croissance

 

9h15-10h45 : Table ronde animée par Coralie Bouisset, Les Carnets Santé

 

  • Caroline LENE, MD101 Consulting - Expert en stratégie réglementaire US (510k, De novo)
  • Guillaume VIALLANEIX, MedTech Momentum, Inc. – Société américaine (Floride) spécialisée dans l’accès au marché US (Business Development, Marketing)
  • Arnaud BUTZBACH, co-fondateur de MEDIAN TECHNOLOGIES – Retour d’expérience sur le marché américain d’une medtech locale
  • Frédéric NOUAILLE, Audit et Risk Solutions – La gestion des risques sur le marché américain
  • Gavin SPENCER, Nicox – Retour d’expérience : le rôle des investisseurs américains et l’impact des décisions de la FDA sur la stratégie globale de l’une des plus anciennes biotech azuréennes

 

11h00-11h10 : L’accompagnement CCI International – Julie THUET, CCI International

 

11h10-11h20 : Le partenariat Eurobiomed – Biocom, un levier pour faciliter le développement des biotech-medtech à San Diego - Camille SUMNER, Eurobiomed

 

11h30 – 13h30 : Cocktail déjeunatoire et RdV B2B avec les experts présents

    INSCRIPTIONS ICI